Jennifer McCue

Jennifer McCue is an accomplished executive with extensive experience in patient advocacy and engagement within the pharmaceutical and healthcare sectors. Currently serving as the Executive Director of Global Patient Advocacy and Engagement at Ultragenyx, Jennifer revolutionizes patient-centric program development and enhances community engagement processes. Previous roles include Director of Global Patient Advocacy and Engagement at The Janssen Pharmaceutical Companies of Johnson & Johnson and Director of Patient Advocacy and Engagement at Momenta Pharmaceuticals. Jennifer's strategic leadership has significantly improved patient access to therapies, secured over $600 million for diabetes research while at JDRF International, and developed comprehensive patient engagement plans across various organizations. With a strong educational background in social policy and philosophy from prestigious institutions including the University of Chicago and the University of Oxford, Jennifer effectively influences healthcare policy and advocacy at multiple levels.